KEVIN S WEIBEL
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TULSA, OK NPI 1104864016
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology OK NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$3,962.99
- Category: General Payments
- Program years: PY2018–2024
- Record count: 195
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,019.28 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.03 | 28 |
| Long term medical supply or device loan | $299.10 | 3 |
| Education | $81.15 | 5 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $382.29 | 7 |
| Acerta Pharma LLC | $174.60 | 4 |
| Daiichi Sankyo Inc. | $88.71 | 4 |
| Ipsen Biopharmaceuticals, Inc | $81.15 | 5 |
| Genentech USA, Inc. | $46.14 | 2 |
| GlaxoSmithKline, LLC. | $31.78 | 2 |
| E.R. Squibb & Sons, L.L.C. | $28.96 | 1 |
| Incyte Corporation | $24.68 | 1 |
| PFIZER INC. | $20.02 | 1 |
| Agios Pharmaceuticals, Inc. | $19.38 | 1 |
| Regeneron Healthcare Solutions, Inc. | $19.03 | 1 |
| Merck Sharp & Dohme Corporation | $16.64 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.09 | 1 |
| Acrotech Biopharma Inc. | $15.02 | 1 |
| Astellas Pharma US Inc | $14.77 | 1 |
| SOBI, INC | $14.43 | 1 |
| GENZYME CORPORATION | $13.45 | 1 |
| EISAI INC. | $13.14 | 1 |
By program year
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.